Molecular and physiological actions of quercetin: Need for clinical trials to assess its benefits in human disease

Nutrition Reviews

Volumn 72, Issue 11, 2014, Pages 720-734

  Miles, Sarah L ^a   Mcfarland, Margaret ^a   Niles, Richard M ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Molecular actions; Physiological actions; Quercetin

Indexed keywords

QUERCETIN; PLANT EXTRACT;

AGING; ARTICLE; CANCER CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; EXERCISE TOLERANCE; GENERAL ASPECTS OF DISEASE; HUMAN; IMMUNE SYSTEM; MAMMAL CELL; NONHUMAN; OBESITY; PHYSIOLOGICAL PROCESS; PLANT; ANIMAL; CHEMISTRY; MEDICAL RESEARCH; METABOLISM;

ANIMALS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; PLANT EXTRACTS; QUERCETIN;

EID: 84908892295     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12152     Document Type: Article

References (101)

1. US Department of Agriculture. USDA Database for the Flavonoid Content of Selected Foods, Release 3.1. Published December 2013. Available at: http://www.ars.usda.gov/Services/docs.htm?docid=6231. Accessed February 2014.
2. Razavi SM, Zahri S, Zarrini G, etal. Biological activity of quercetin-3-O-glucoside, a known plant flavonoid. Bioorg Khim. 2009;35:376-378.
3. 2. Plant Physiol. 1997;115:1405-1412.
4. Harwood M, Nielewska-Nikiel B, Borzelleca JF, etal. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 2007;45:2179-2205.
5. Murota K, Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys. 2003;417:12-17.
6. Manach C, Williamson G, Morand C, etal. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81(Suppl):230S-242S.
7. Walle T, Walle UK, Halunshka PV. Carbon dioxide is the major metabolite of quercetin in humans. J Nutr. 2001;131:2648-2652.
8. Moon YJ, Wang L, Dicanzo R, etal. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos. 2008;29:205-217.
9. Egert S, Wolffram S, Bosy-Westphal A, etal. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr. 2008;138:1615-1621.
10. Ferry DR, Smith A, Malkhandi J, etal. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996;2:659-668.
11. Lamson DW, Brignall MS. Antioxidants and cancer, part 3: quercetin. Altern Med Rev. 2000;5:196-208.
12. Min K, Ebeler SE. Quercetin inhibits hydrogen peroxide-induced DNA damage and enhances DNA repair in CaCo-2 cells. Food Chem Toxicol. 2009;47:2716-2722.
13. Thangasamy T, Sittadjody S, Linesand KH, etal. Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbizine. Cell Oncol. 2008;30:371-387.
14. Plaumann B, Fritsche M, Rimpler H, etal. Flavonoids activate wild-type p53. Oncogene. 1996;13:1605-1614.
15. Tanigawa S, Fujii M, Hou DX. Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Biosci Biotechnol Biochem. 2008;72:797-804.
16. Tan J, Wang B, Zu L. Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin. Chem Biodivers. 2009;6:1101-1110.
17. Zhang Q, Zhao XH, Wang ZJ. Flavones and flavonols exert cytotoxic effects on a human esophageal adenocarcinoma cell line by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol. 2008;46:2042-2053.
18. Kimura S, Warabi E, Yanagawa T, etal. Essential role of Nrf2 in keratinocyte protection from UVA by quercetin. Biochem Biophys Res Commun. 2009;387:109-114.
19. Wang L, Lin SQ, Kiu G, etal. Protective effects of quercetin on cadmium-induced cytotoxicity in primary cultures of rat proximal tubular cells. Biomed Environ Sci. 2013;26:258-267.
20. Piantelli M, Maggiano N, Ricci R, etal. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J Invest Dermatol. 1995;105:248-253.
21. Miodini P, Fioravanti L, Di Fronzo G, etal. The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. Br J Cancer. 1999;80:1150-1155.
22. Maggiolini M, Bonofiglio D, Marsico S, etal. Estrogen receptor α mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol. 2001;60:595-602.
23. Bulzomi P, Galluzzo P, Bolli A, etal. The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals. J Cell Physiol. 2012;227:1891-1898.
24. Maggiolini M, Vivacqua A, Fasanella G, etal. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem. 2004;279:27008-27016.
25. Elia G, Santoro MG. Regulation of heat shock protein synthesis by quercetin in human erythroleukemia cells. Biochem J. 1994;300:201-209.
26. Nagai N, Nakai A, Nagata K. Quercetin suppresses heat shock response by down regulation of HSF1. Biochem Biophys Res Commun. 1995;208:1099-1105.
27. Aalinkeel R, Bindukumar B, Reynolds JL, etal. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate. 2008;68:1773-1789.
28. Wang RE, Kao JL, Hilliard CA, etal. Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. J Med Chem. 2009;52:1912-1921.
29. Jakubowciz-Gil J, Rzeski W, Zdzisinska B, etal. Different sensitivity of neurons and neuroblastoma cells to quercetin treatment. Acta Neurobiol Exp (Wars). 2008;68:463-476.
30. Ishizawa K, Ixawa-Ishizawa Y, Ohnishi S, etal. Quercetin glucuronide inhibits cell migration and proliferation by PDGF in vascular smooth muscle cells. J Pharmacol Sci. 2009;109:257-264.
31. Moon SK, Cho GO, Jung SY, etal. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun. 2003;301:1069-1078.
32. Spencer JP, Rice-Evans C, Williams RJ. Modulation of pro-survival Akt/protein kinase B and ERK/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem. 2003;278:34783-34793.
33. Youl E, Bardy G, Magous R, etal. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol. 2010;161:799-814.
34. Min YD, Choi CH, Bark H, etal. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-κβ and p38 MAPK in HMC-1 human mast cell line. Inflamm Res. 2007;56:210-215.
35. Granado-Serrano AB, Martin MA, Bravo L, etal. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact. 2011;195:154-164.
36. Perez-Vizcaino F, Bishop-Bailley D, Lodi F, etal. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells. Biochem Biophys Res Commun. 2006;346:919-925.
37. Granado-Serrano AB, Martin MA, Bravo L, etal. Quercetin modulates NF-κB and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr Cancer. 2010;62:390-401.
38. Hackl LP, Cuttle G, Dovichi SS, etal. Inhibition of angiotensin-converting enzyme by quercetin alters vascular response to bradykinin and angiotensin I. Pharmacology. 2002;65:182-186.
39. Loizzo ML, Said A, Tundis R, etal. Inhibition of angiotensin-converting enzyme (ACE) by flavonoids isolated from Ailanthus excels (Roxb) (Simaroubaceae). Phytother Res. 2007;21:32-36.
40. Triantafyllou A, Liakos P, Tsakalof A, etal. The flavonoid quercetin induces hypoxia-inducible factor-1α (HIF-1α) and inhibits cell proliferation by depleting intracellular iron. Free Radic Res. 2007;41:342-356.
41. Cantero G, Campanella C, Mateos S, etal. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin. Mutagensis. 2006;21:321-325.
42. Bensasson RV, Zoeti V, Josany A, etal. Potency of inhibition of human DNA topoisomerase I by flavones assessed through physicochemical parameters. Free Radic Biol Med. 2011;51:1406-1410.
43. Lamy E, Goetz V, Erlacher M, etal. hTERT: another brick in the wall of cancer cells. Mutat Res. 2013;752:119-128.
44. Naasani I, Oh-Hashi F, Oh-Hara T, etal. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 2003;63:824-830.
45. Kw L, Kang NJ, Heo YS, etal. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res. 2008;68:946-955.
46. Walker EH, Pacold ME, Perisic O, etal. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine. Mol Cell. 2000;6:909-919.
47. Peet GW, Liu J. IκB kinases α and β show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin. J Biol Chem. 1999;274:32655-32661.
48. Park CH, Chang JY, Hahn ER, etal. Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun. 2005;328:227-234.
49. + influx and exocytosis in rat peritoneal mast cells. Biochim Biophys Acta. 1997;469:52-69.
50. Schwartz A, Sutton SL, Middleton E Jr. Quercetin inhibition of the induction and function of cytotoxic T lymphocytes. Immunopharmacology. 1982;4:125-138.
51. Manjeet KR, Gosh B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-α production in murine macrophages. Int J Immunopharmacol. 1999;21:435-443.
52. Kampkotter A, Timpel C, Zurawski RE, etal. Increase of stress resistance and lifespan of C. elegans by quercetin. Comp Biochem Physiol B Biochem Mol Biol. 2008;149:314-323.
53. Jones E, Hughes RE. Quercetin, flavonoids and the life-span of mice. Exp Gerontol. 1982;17:213-217.
54. Chondrogianni N, Kapeta S, Chinou I, etal. Anti-ageing and rejuvenating effects of quercetin. Exp Gerontol. 2010;45:763-771.
55. Nieman DC, Henson DA, Davis JM, etal. Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol. 2007;103:1728-1735.
56. Nieman DC, Henson DA, Davies M, etal. Quercetin ingestion does not alter cytokine changes in athletes competing in the Western States Endurance Run. J Interferon Cytokine Res. 2007;27:1003-1011.
57. Davis JM, Murphy EA, Carmichael MD, etal. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol. 2009;296:R1071-R1077.
58. Nieman DC, Williams AS, Shanely RA, etal. Quercetin's influence on exercise performance and muscle mitochondrial biogenesis. Med Sci Sports Exerc. 2010;42:338-345.
59. Pelletier DM, Lacerte G, Goulet EDB. Effects of quercetin supplementation on endurance performance and maximal oxygen consumption: a meta-analysis. Int J Sport Nutr Exerc Metab. 2013;23:73-82.
60. Askari G, Ghiasvand R, Paknahad Z, etal. The effects of quercetin supplementation on body composition, exercise performance and muscle damage indices in athletes. Int J Prev Med. 2013;4:21-26.
61. Rivera L, Moron R, Sanchez M, etal. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity. 2008;16:2081-2087.
62. Ahn J, Lee H, Kim S, etal. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun. 2008;373:545-549.
63. Varma SD, Mizuno A, Kinoshita JH. Diabetic cataracts and flavonoids. Science. 1977;195:205-206.
64. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxoicol Pharmacol. 2003;135C:357-364.
65. Kobori N, Masumoto S, Akimoto Y, etal. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res. 2009;53:859-868.
66. Youl E, Bardy G, Magous R, etal. Quercetin potentiates insulin secretion and protects IND-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol. 2010;161:799-814.
67. Edwards RL, Lyon SE, Rabovsky A, etal. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007;137:2405-2411.
68. Remberg P, Bjork L, Hedner T, etal. Characteristics, clinical effect profile and tolerability of a nasal spray preparation of Artemisia abrotanum L. for allergic rhinitis. Phytomedicine 2004;11:36-42.
69. Lugli E, Ferraresi R, Roat E, etal. Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. Leuk Res. 2009;33:140-150.
70. Heinz SA, Henson DA, Nieman DC, etal. A 23-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br J Nutr. 2010;104:849-857.
71. Jung JH, Kang JL, Kim HS. Effect of quercetin on impaired immune function in mice exposed to irradiation. Nutr Res Pract. 2012;6:301-307.
72. Singh A, Naidu PS, Kulkarni SK. Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin, a bioflavonoid. Free Radic Res. 2003;37:1245-1252.
73. Ho L, Ferruzzi MG, Janie EM, etal. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J. 2013;27:769-781.
74. Saul N, Pietsch K, Menzel R, etal. Quercetin-mediated longevity in C. elegans: is DAF-16 involved? Mech Ageing Dev. 2008;129:611-613.
75. Pietsch K, Saul N, Swain SC, etal. Meta-analysis of global transcriptomics suggests that conserved genetic pathways are responsible for quercetin and tannic acid mediated longevity in C. elegans. Front Genet. 2012;3:48. doi: 10.3389/fgene.2012.00048.
76. Kobori M, Masumoto S, Akimoto Y, etal. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res. 2011;55:530-540.
77. Panchal SK, Poudyal H, Brown L. Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J Nutr. 2012;142:1026-1032.
78. Asgary S, Naderi G, Sarrafrzadegan N, etal. Anit-oxidant effect of flavonoids on hemoglobin glycosylation. Pharm Acta Helv. 1999;73:223-236.
79. Babujanarthanam R, Kavitha P, Pandian MR. Quercetin, a bioflavonoid improves glucose homeostasis in steptozotocin-induced diabetic tissues by altering glycolytic and gluconeogenic enzymes. Fundam Clin Pharmacol. 2010;24:357-364.
80. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med. 2010;31:478-494.
81. Larson AJ, Symons JD, Jalili T. Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Adv Nutr. 2012;3:39-46.
82. Knekt P, Jarvinen R, Renuanen A, etal. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ. 1996;312:478-481.
83. Egert S, Bosy-Westphal A, Seiberl J, etal. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr. 2009;102:1065-1074.
84. Olaleye M, Crown O, Akinmoladun A, etal. Rutin and quercetin show greater efficacy than nifedipin in ameliorating hemodynamic, redox, and metabolite imbalances in sodium chloride-induced hypertensive rats. Hum Exp Toxicol. 2013;33:602-608.
85. Scambia G, Ranelletti FO, Benedetti PP, etal. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast cancer cell line expressing type II estrogen-binding sites. Cancer Chemother Pharmacol. 1991;28:255-258.
86. Scambia G, Ranelletti FO, Panici PB, etal. Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol. 1994;34:459-464.
87. Sliutz G, Kariseder J, Tempfer C, etal. Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitizer in chemotherapy. Br J Cancer. 1996;74:172-177.
88. Priego S, Feddi F, Ferrer P, etal. Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts and chemo-radiotherapy: a Bcl-2 and superoxide dismutase 2-dependent mechanism. Mol Cancer Ther. 2008;10:3330-3342.
89. Azevedo MI, Pereira AF, Nogueira RB, etal. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Mol Pain. 2013;9:53. doi: 10.1186/1744-8069-9-53.
90. Du G, Lin H, Wang M, etal. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells. Cancer Chemother Pharmacol. 2010;65:277-287.
91. Chen C, Zhou J, Chunyan J. Quercetin: a potential drug to reverse multidrug resistance. Life Sci. 2010;87:333-338.
92. Thangasamy T, Sittadjody S, Mitchell GC, etal. Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73. BMC Cancer. 2010;10:282. doi: 10.1186/1471-2407-10-282.
93. Castresana JS, Rubio MP, Vazquez JJ, etal. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer. 1993;55:562-565.
94. Papp T, Jafari M, Schiffmann D. Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions. J Cancer Res Clin Oncol. 1996;122:541-548.
95. Hsu H-S, Lin J-H, Huang W-C. Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer. 2011;117:1516-1528.
96. Nessa MU, Beale P, Chan C, etal. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumor models. Anticancer Res. 2011;31:3789-3798.
97. Pozsgai E, Bellyei S, Cseh A, etal. Quercetin increases the efficacy of glioblastoma treatment compared to standard chemoradiotherapy by suppression of the PI-3-kinase-Akt pathway. Nutr Cancer. 2013;65:1059-1066.
98. Xavier CPR, Lima CF, Rohde M, etal. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemother Pharmacol. 2011;68:1449-1457.
99. Xin LC, Wen-Yu W, Yao C, etal. Quercetin enhances the effects of 5-fluorouracil-mediated growth inhibition and apoptosis of esophageal cancer cells by inhibiting NF-κB. Oncol Lett. 2012;4:775-778.
100. Berndt K, Campanile C, Muff R, etal. Evaluation of quercetin as a potential drug in osteosarcoma treatment. Anticancer Res. 2013;33:1297-1306.
101. Shoskes DA, Zeitlin SI, Shahed A, etal. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 1999;54:960-963.